GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
T42.2X5S
Adverse effect of succinimides and oxazolidinediones, sequela
ICD10CM code
Similar Codes
ICD10CM codes
T42.2X5S
- Adverse effect of succinimides and oxazolidinediones, sequela
T42.2X5
- Adverse effect of succinimides and oxazolidinediones
T42.2X6S
- Underdosing of succinimides and oxazolidinediones, sequela
T42.2X5D
- Adverse effect of succinimides and oxazolidinediones, subsequent encounter
T42.2X5A
- Adverse effect of succinimides and oxazolidinediones, initial encounter
T42.2X1S
- Poisoning by succinimides and oxazolidinediones, accidental (unintentional), sequela
T42.2X4S
- Poisoning by succinimides and oxazolidinediones, undetermined, sequela
T42.2X3S
- Poisoning by succinimides and oxazolidinediones, assault, sequela
T42.2X2S
- Poisoning by succinimides and oxazolidinediones, intentional self-harm, sequela
T42.2X
- Poisoning by, adverse effect of and underdosing of succinimides and oxazolidinediones
HCPCS codes
G8494
- All quality actions for the applicable measures in the diabetes mellitus (dm) measures group have be
G0246
- Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy
G8506
- Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb
G8485
- I intend to report the diabetes mellitus (dm) measures group
G8935
- Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (
J0330
- Injection, succinylcholine chloride, up to 20 mg
G8473
- Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescrib
G0245
- Initial physician evaluation and management of a diabetic patient with diabetic sensory neuropathy r
S9455
- Diabetic management program, group session
S9141
- Diabetic management program, follow-up visit to md provider
CPT4 codes
5010F
- Findings of dilated macular or fundus exam communicated to the physician or other qualified health c
86337
- Insulin antibodies
80168
- Ethosuximide
82943
- Glucagon
80161
- Carbamazepine; -10,11-epoxide
4328F
- Patient (or caregiver) queried about sleep disturbances (Prkns)
60699
- Unlisted procedure, endocrine system
80203
- Zonisamide
85305
- Clotting inhibitors or anticoagulants; protein S, total
3085F
- Suicide risk assessed (MDD, MDD ADOL)